April 8, 2026 BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
April 7, 2026 SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Navan, Inc. (NAVN)
April 7, 2026 Impeccable boxed space toys plus rarities from the Batcave led Milestone’s Premier Antique Toy Action
